Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citation
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
Items 601–700 of 1,004
Doutreleau, S., Ulliel‐Roche, M., Hancco, I., Bailly, S., Oberholzer, L., Robach, P., Brugniaux, J. V., Pichon, A., Stauffer, É., Perger, E., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac166 · Cited by 30
Masson, B., Willer, A. S., Dutheil, M., Penalva-Mousset, L., Ribeuz, H. L., Jekmek, K. E., Ruchon, Y., Cohen‐Kaminsky, S., Sabourin, J., Humbert, M. J. C., et al. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00011.2023 · Cited by 30
Self-citationZhao, C., Le, X., Li, M., Hu, Y., Li, X., Chen, Z., Hu, G., Hu, L., & Li, Q. (2023) · Respiratory Research · doi:10.1186/s12931-023-02600-5 · Cited by 30
Diagnosis and management of autoimmune diseases in the ICU
Dumas, G., Arabi, Y. M., Bartz, R. R., Ranzani, O., Scheibe, F., Darmon, M., & Helms, J. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07266-7 · Cited by 30
Helmersen, D., Provencher, S., Hirsch, A. M., Dam, A. V., Dennie, C. J., de Perrot, M. E., Mielniczuk, L. M., Hirani, N., Chandy, G., Swiston, J. R., et al. (2019) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2019.1631663 · Cited by 30
Genetic Predisposition to High-Altitude Pulmonary Edema
Eichstaedt, C. A., Mairbäurl, H., Song, J., Benjamin, N., Fischer, C., Dehnert, C., Schommer, K., Berger, M. M., Bärtsch, P., Grünig, E., et al. (2020) · High Altitude Medicine & Biology · doi:10.1089/ham.2019.0083 · Cited by 30
Callejo, M., Mondéjar‐Parreño, G., Esquivel‐Ruiz, S., Olivencia, M. A., Moreno, L., Blanco, I., Subías, P. E., Cogolludo, A. L., Barberà, J. A., & Pérez‐Vizcaíno, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020448 · Cited by 30
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1
Jutant, E., Jaïs, X., Girerd, B., Savale, L., Ghigna, M., Perros, F., Mignard, X., Jevnikar, M., Bourlier, D., Prévôt, G., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0105oc · Cited by 30
Self-citationHeart rate monitoring improves clinical assessment during 6‐min walk
Lachant, D. J., Light, A., Offen, M., Adams, J. P., & White, R. J. (2020) · Pulmonary Circulation · doi:10.1177/2045894020972572 · Cited by 29
Pulmonary arterial hypertension in systemic sclerosis
Lechartier, B., & Humbert, M. J. C. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104062 · Cited by 29
Song, J.-L., Zheng, S., He, R., Gui, L., Lin, M., & Sham, J. S. K. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106860 · Cited by 29
Mukoyama, H., Shirakashi, M., Tanaka, N., Iwasaki, T., Nakajima, T., Onizawa, H., Tsuji, H., Kitagori, K., Akizuki, S., Nakashima, R., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02675-9 · Cited by 29
Kwan, E. D., Vélez‐Rendón, D., Zhang, X., Mu, H., Patel, M., Pursell, E., Stowe, J. C., & Valdez‐Jasso, D. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00046.2021 · Cited by 29
Gredic, M., Wu, C., Hadžić, S., Pak, O., Savai, R., Kojonazarov, B. K., Doswada, S., Weiß, A., Weigert, A., Günther, A., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01153-2021 · Cited by 29
Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease
Buehler, P. W., Swindle, D. C., Pak, D. I., Ferguson, S. K., Majka, S. M., Karoor, V., Moldovan, R., Sintas, C., Black, J., Gentinetta, T., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.08.238 · Cited by 29
Aldhahir, A. M., Alghamdi, S. M., Alqahtani, J. S., Alqahtani, K. A., Rajah, A. M. A., Alkhathlan, B. S., Singh, S. J., Mandal, S., & Hurst, J. R. (2021) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_639_20 · Cited by 29
Ho, L., Hossen, M. N., Nguyen, T. B., Vo, A., & Ahsan, F. (2022) · Biomedicines · doi:10.3390/biomedicines10010170 · Cited by 29
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden
Maron, B. A., & Humbert, M. J. C. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0011 · Cited by 29
Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart
Alenezi, F. A. M., Covington, T. A., Mukherjee, M., Mathai, S. C., Yu, P. B., & Rajagopal, S. (2022) · Circulation Research · doi:10.1161/circresaha.121.319990 · Cited by 29
Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα
Cai, Z., Tian, S., Klein, T., Tu, L., Geenen, L. W., Koudstaal, T., van den Bosch, A. E., de Rijke, Y. B., Reiss, I. K. M., Boersma, E. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15039-3 · Cited by 29
El-Adili, F., Lui, J. K., Najem, M. S., Farina, G. A., Trojanowska, M., Sam, F., & Bujor, A. M. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02943-2 · Cited by 29
Held, M., Pfeuffer-Jovic, E., Wilkens, H., Güder, G., Küsters, F., Schäfers, H., Langen, H. J., Cheufou, D. H., & Schmitt, D. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107177 · Cited by 29
Linee guida ESC/ERS 2022 per la diagnosi e il trattamento dell’ipertensione polmonare
Humbert, M. J. C., Kovács, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Subías, P. E., Ferrari, P., et al. (2023) · Giornale italiano di cardiologia · doi:10.1714/4014.39906 · Cited by 29
Self-citationJani, V., Aslam, M. I., Fenwick, A. J., Ma, W., Gong, H. M., Milburn, G. N., Nissen, D. L., Salazar, I. M. C., Hanselman, O., Mukherjee, M., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064717 · Cited by 30
Natural history of chronic thromboembolic pulmonary disease with no or mild pulmonary hypertension
Reddy, S. A., Świetlik, E. M., Robertson, L., Michael, A., Boyle, S., Polwarth, G. J., Screaton, N., Ruggiero, A., Nethercott, S. L., Taboada, D., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.04.016 · Cited by 29
Yan, X., Huang, J., Zeng, Y., Zhong, X., Fu, Y., Xiao, H., Wang, X., Lian, H., Luo, H., Li, D., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116093 · Cited by 30
Pulmonary Hypertension in General Cardiology Practice
Calderaro, D., Alves, J. L., Fernandes, C. J. C. D. S., & Souza, R. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190188 · Cited by 29
Self-citationMatrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
Arvidsson, M., Ahmed, A., Bouzina, H., & Rådegran, G. (2019) · Pulmonary Circulation · doi:10.1177/2045894019895414 · Cited by 29
The Biological Bases of Group 2 Pulmonary Hypertension
Fernández, A. I., Yotti, R., González‐Mansilla, A., Mombiela, T., Gutiérrez, E., del Villar, C. P., Navas-Tejedor, P., Chazo, C., Martínez‐Legazpi, P., Fernández‐Avilés, F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235884 · Cited by 29
Mulvaney, E. P., Reid, H. M., Bialešová, L., Bouchard, A., Salvail, D., & Kinsella, B. T. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1113-2 · Cited by 29
Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension
Fazal, S., Bisserier, M., & Hadri, L. (2021) · Cells · doi:10.3390/cells10030638 · Cited by 29
Wojciuk, M., Ciołkiewicz, M., Kuryliszyn-Moskal, A., Chwieśko-Minarowska, S., Sawicka, E., Ptaszyńska‐Kopczyńska, K., & Kamiński, K. A. (2021) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-021-00315-y · Cited by 29
Li, H., Zhang, Y., Wang, S., Yuan, Y., Liu, Q., Huang, S., Peng, H., Zhang, Y., Zeng, W., & Wu, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.756226 · Cited by 29
del Valle, K. T., & DuBrock, H. M. (2021) · Wiley eBooks · doi:10.1002/cphy.c210009 · Cited by 29
Lin, C., Ge, Q., Wang, L., Zeng, P., Huang, M., & Li, D. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2368082 · Cited by 28
Oxygen and pulmonary arterial hypertension: effects, mechanisms, and therapeutic benefits
Green, S., & Stuart, D. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa001 · Cited by 28
Baroutidou, A., Arvanitaki, A., Hatzidakis, A. A., Pitsiou, G., Ziakas, A., Karvounis, H. I., & Giannakoulas, G. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030633 · Cited by 28
Wang, R., Yuan, T., Chen, D., Chen, Y.-C., Sun, S., Wang, S., Kong, L., Fang, L., & Du, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.844400 · Cited by 28
Suresh, S., Charlton, D., Snell, E. K., Laffoon, M., Medsger, T. A., Zhu, L., & Domsic, R. T. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42152 · Cited by 28
Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension
Lachant, D. J., Kennedy, E., Derenze, B., Light, A., Lachant, M., & White, R. J. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.06.025 · Cited by 28
Maron, B. A., Kleiner, D. E., Arons, E., Wertheim, B. M., Sharma, N., Haley, K. J., Samokhin, A. O., Rowin, E. J., Maron, M. S., Rosing, D. R., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.040 · Cited by 28
Cardiac complications in thalassemia throughout the lifespan: Victories and challenges
Wood, J. C. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15078 · Cited by 28
Gertz, R. J., Gerhardt, F., Pienn, M., Lennartz, S., Kröger, J. R., Caldeira, L., Pennig, L., Schömig, T., Hokamp, N. G., Maintz, D. C., et al. (2023) · European Radiology · doi:10.1007/s00330-023-10337-4 · Cited by 28
Kumar, S., Mickael, C. S., Kumar, R., Prasad, R. R., Campbell, N. V., Zhang, H., Li, M., McKeon, B. A., Allen, T. E., Graham, B. B., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1372959 · Cited by 28
Kasai, T., Kohno, T., Shimizu, W., Ando, S., Joho, S., Osada, N., Kato, M., Kario, K., Shiina, K., Tamura, A., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0489 · Cited by 28
Wang, R., Wang, J., Yu, J. Q., Li, Z., Zhang, M., Chen, Y., Liu, F., Jiang, D., Guo, J., Li, X., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06384-8 · Cited by 28
Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease
Günther, S., Perros, F., Rautou, P., Girerd, B., Ghigna, M., Cazals-Hatem, D. L., Lau, E., Dorfmüller, P., Sitbon, O., Valla, D. C., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.02.007 · Cited by 28
Self-citationTreatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway
Beghetti, M., Gorenflo, M., Ivy, D. D., Moledina, S., & Bonnet, D. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24442 · Cited by 28
Yılmaz, A., Bauersachs, J. K., Kindermann, I., Klingel, K., Knebel, F., Meder, B., Morbach, C., Nagel, E. C., Schulze‐Bahr, E., Siepen, F. A. D., et al. (2019) · Der Kardiologe · doi:10.1007/s12181-019-00344-5 · Cited by 28
Long noncoding RNAs: emerging roles in pulmonary hypertension
Jin, Q., Zhao, Z., Zhao, Q., Yu, X. L., Yan, L., Zhang, Y., Luo, Q., & Liu, Z. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09866-2 · Cited by 28
Yu, M., Peng, L., Liu, P., Yang, M., Zhou, H., Ding, Y., Wang, J., Huang, W. R. H., Tan, Q., Wang, Y., et al. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s235207 · Cited by 28
Schweintzger, S., Köestenberger, M., Schlagenhauf, A., Grangl, G., Burmas, A., Kurath‐Koller, S., Pocivalnik, M., Sallmon, H., Baumgartner, D., Hansmann, G., et al. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2020.04.01 · Cited by 28
Stem/Progenitor Cells and Pulmonary Arterial Hypertension
Pu, X., Du, L., Hu, Y., Fan, Y., & Xu, Q. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315052 · Cited by 28
Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer
Funk-Hilsdorf, T. C., Behrens, F., Grune, J., & Simmons, S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.819145 · Cited by 28
Duan, Y., Zhou, X., Su, H., Jiang, K., Wu, W., Pan, X., Qi, G., Zhang, Y., & Cao, Y. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.09.14 · Cited by 27
Balloon Pulmonary Angioplasty: State of the Art
Coghlan, G., Rothman, A. M. K., & Hoole, S. P. (2021) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2020.14 · Cited by 27
SOX17 Loss-of-Function Mutation Underlying Familial Pulmonary Arterial Hypertension
Wang, T.-M., Wang, S., Xu, Y., Zhao, C., Qiao, X.-H., Yang, C., Liu, X., & Yang, Y. (2021) · International Heart Journal · doi:10.1536/ihj.20-711 · Cited by 27
DuBrock, H. M., Burger, C. D., Bartolome, S., Feldman, J. P., Ivy, D. D., Rosenzweig, E. B., Sager, J. S., Presberg, K. W., Mathai, S. C., Lammi, M. R., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211020913 · Cited by 27
Self-citationSleep apnea and pulmonary hypertension: A riddle waiting to be solved
Sharma, S., Stansbury, R. C., Hackett, B., & Fox, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107935 · Cited by 27
Clinical Presentation and Treatment of High-Risk Sarcoidosis
Perlman, D., Sudheendra, M. T., Furuya, Y., Shenoy, C., Kalra, R., Roukoz, H., Markowitz, J., Maier, L. A., & Bhargava, M. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202102-212cme · Cited by 27
Hansmann, G., Diekmann, F., Chouvarine, P., Ius, F., Carlens, J., Schwerk, N., Warnecke, G., Vogel‐Claussen, J., Hohmann, D., Alten, T. A., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.10.014 · Cited by 27
The Role of Glutamine and Glutaminase in Pulmonary Hypertension
Wang, S., Yan, Y., Xu, W., Gong, S., Zhong, X.-J., An, Q.-Y., Zhao, Y., Liu, J., Wang, L., Yuan, P., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.838657 · Cited by 27
del Castillo, A. G., López‐Meseguer, M., Fonollosa‐Pla, V., Sáez, B., Colunga-Argüelles, D., Revilla‐López, E., Rubio‐Rivas, M., Ropero, M. J. C., Argibay, A. B., Barberà, J. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09353-z · Cited by 27
Perez, J. M., Melvin, P. R., Berry, J. G., Mullen, M. P., & Graham, R. J. (2022) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000003002 · Cited by 27
Åberg, M., Björklund, E., Wikström, G., & Christersson, C. (2022) · Platelets · doi:10.1080/09537104.2022.2087867 · Cited by 27
Matas-García, A., del Castillo, A. G., Kisluk, B., Selva-O’Callaghan, A., Espinosa, G., Prieto‐González, S., Moreno, P., Garrabou, G., Grau‐Junyent, J. M., Simeón‐Aznar, C. P., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keac361 · Cited by 27
Sanges, S., Guerrier, T., Duhamel, A., Guilbert, L., Hauspie, C., Largy, A., Balden, M., Podevin, C., Lefèvre, G., Jendoubi, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954007 · Cited by 27
Coursen, J. C., Simpson, C. E., Mukherjee, M., Vaught, A. “. J., Kutty, S., Al‐Talib, T. K., Wood, M. J., Scott, N. S., Mathai, S. C., & Sharma, G. V. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9080260 · Cited by 27
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study
Ruaro, B., Confalonieri, P., Caforio, G., Baratella, E., Pozzan, R., Tavano, S., Bozzi, C., Lerda, S., Geri, P., Biolo, M., et al. (2022) · Medicina · doi:10.3390/medicina58081094 · Cited by 27
Fauché, A., Presles, É., Sanchez, O., Jaïs, X., Mao, R. L., Robin, P., Pernod, G., Bertoletti, L., Jégo, P., Parent, F., et al. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15866 · Cited by 27
Self-citationRivière, A., Picard, C., Berastegui, C., Cuesta, V. M. M., Bunel, V., Godinas, L., Salvaterra, E., Rossetti, V., Savale, L., Israël‐Biet, D., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17177 · Cited by 27
A century of exercise physiology: lung fluid balance during and following exercise
Miserocchi, G., & Beretta, E. P. (2022) · European Journal of Applied Physiology · doi:10.1007/s00421-022-05066-3 · Cited by 27
Torres, G., Yang, J., Griffiths, M., Brandal, S., Damico, R. L., Vaidya, D. M., Simpson, C. E., Pauciulo, M. W., Nichols, W. C., Ivy, D. D., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12235 · Cited by 27
Aimaier, S., Tao, Y., Fang, L., Yupeng, Z., Wenhui, S., Aikemu, A., & Maimaitiyiming, D. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-03981-2 · Cited by 27
Fairley, J. L., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G., Walker, J. G., Host, L., Morrisroe, K., Apostolopoulous, D., et al. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03059-x · Cited by 27
Zhang, Q., Chen, Y., Wang, Q., Wang, Y., Feng, W., Chai, L., Liu, J., Li, D., Chen, H., Qiu, Y., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02454-x · Cited by 27
Holzer, R. J., Bergersen, L. J., Thomson, J. D., Aboulhosn, J., Aggarwal, V., Akagi, T., Alwi, M., Armstrong, A. K., BACHA, E. A., Benson, L. N., et al. (2023) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2023.101181 · Cited by 27
Deep Learning Based Prediction of Pulmonary Hypertension in Newborns Using Echocardiograms
Ragnarsdóttir, H., Özkan, E., Michel, H., Chin-Cheong, K., Manduchi, L., Wellmann, S. M., & Vogt, J. E. (2024) · International Journal of Computer Vision · doi:10.1007/s11263-024-01996-x · Cited by 27
Saxer, S., Lichtblau, M., Berlier, C., Hasler, E., Schwarz, E. I., & Ulrich, S. (2019) · Lung · doi:10.1007/s00408-019-00248-x · Cited by 27
Pulmonary artery denervation for pulmonary arterial hypertension
Constantine, A. H., & Dimopoulos, K. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.04.005 · Cited by 27
Ribeuz, H. L., Dumont, F., Ruellou, G., Lambert, M., Balliau, T., Quatredeniers, M., Girerd, B., Cohen‐Kaminsky, S., Mercier, O. M., Yen‐Nicolaÿ, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197400 · Cited by 27
Self-citationAkseer, S., Horlick, E. M., Vishwanath, V., Hobbes, B., Huszti, E., Mak, S. S., Lee, D. S., & Abrahamyan, L. (2020) · European Respiratory Review · doi:10.1183/16000617.0099-2020 · Cited by 27
Advanced airway management and respiratory care in decompensated pulmonary hypertension
Vahdatpour, C., Ryan, J. J., Zimmerman, J., MacCormick, S., Palevsky, H. I., Alnuaimat, H., & Ataya, A. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10168-9 · Cited by 27
Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.01.005 · Cited by 27
Self-citationMitochondria in hypoxic pulmonary hypertension, roles and the potential targets
Geng, Y., Hu, Y., Zhang, F., Tuo, Y., Ge, R., & Bai, Z. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1239643 · Cited by 26
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management
Zhang, Y., Li, X., Li, S., Yu, Z., Zhang, T., & Sun, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158427 · Cited by 26
Qiu, F., Miao, H., Hui, H., Qiu, L.-J., Chen, Y., Luo, M., Zhang, J., Lin, Y., Li, D., Ong, S., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326173 · Cited by 26
Aoki, T., Sugimura, K., Terui, Y., Tatebe, S., Fukui, S., Miura, M., Yamamoto, S., Yaoita, N., Suzuki, H., Sato, H., et al. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100579 · Cited by 26
The role of imaging in pulmonary hypertension
Sharma, M., Burns, A., Yap, K., & Prior, D. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-295 · Cited by 26
Pulmonary hypertension: From an orphan disease to a global epidemic
BUTROUS, G. S. (2020) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2020.5 · Cited by 26
Customized Massive Parallel Sequencing Panel for Diagnosis of Pulmonary Arterial Hypertension
Tenorio, J. A., Hernández‐González, I., Gallego, N., Pérez‐Olivares, C., Parra, N. O., Arias, P., de Granda, E. C., Acebo, G. G., Lago‐Docampo, M., Palomino-Doza, J., et al. (2020) · Genes · doi:10.3390/genes11101158 · Cited by 26
Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis
Mukherjee, M., Mercurio, V., Hsu, S., Mayer, S. A., Mathai, S. C., Hummers, L. K., Kass, D. A., Hassoun, P. M., Wigley, F. M., Tedford, R. J., et al. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02237-9 · Cited by 26
DuBrock, H. M., Nathan, S. D., Reeve, B. B., Kolaitis, N. A., Mathai, S. C., Classi, P. M., Nelsen, A. C., Olayinka‐Amao, B., Norcross, L., & Martin, S. A. (2021) · Pulmonary Circulation · doi:10.1177/20458940211005641 · Cited by 26
The role of immune cells in pulmonary hypertension: Focusing on macrophages
Luo, P., & Qiu, B. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.11.006 · Cited by 26
Yung, D., Jackson, E. O., Blumenfeld, A., Redding, G., DiGeronimo, R., McGuire, J. K., Riker, M., Tressel, W., Berkelhamer, S. K., & Eldredge, L. C. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1077422 · Cited by 26
Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension
Tsubata, H., Nakanishi, N., Itatani, K., Takigami, M., Matsubara, Y., Ogo, T., Fukuda, T., Matsuda, H., & Matoba, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-33727-6 · Cited by 26
Angelis, R. D., Riccieri, V., Cipolletta, E., Papa, N. D., Ingegnoli, F., Bosello, S. L., Spinella, A., Pellegrino, G., de Pinto, M., Papa, S., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead445 · Cited by 26
Distler, O., Bonderman, D., Coghlan, G., Denton, C. P., Grünig, E., Khanna, D., McLaughlin, V. V., Müller‐Ladner, U., Pope, J. E., Vonk, M. C., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42791 · Cited by 26
Self-citationShlobin, O. A., Shen, E., Wort, S. J., Piccari, L., Scandurra, J., Hassoun, P. M., Nikkho, S. M., & Nathan, S. D. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12310 · Cited by 26
Tabosh, T. A., Liu, H., Koça, D., Tarrass, M. A., Tu, L., Giraud, S., Delagrange, L., Beaudoin, M., Rivière, S., Grobost, V., et al. (2024) · Angiogenesis · doi:10.1007/s10456-023-09902-8 · Cited by 26
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.